The C. diff toxin test checks a stool sample to find out whether the bacterium Clostridioides difficile is actively producing the toxins that cause diarrhea and colitis. This matters because C. difficile can live quietly in the gut without causing harm, so the central question is not simply whether the germ is present, but whether it is making you sick. Clostridioides difficile, formerly called Clostridium difficile and often shortened to C. diff, releases two toxins known as toxin A and toxin B, and these toxins drive the disease.
In this article you’ll learn what the C. diff toxin test measures, how the main testing methods differ, how clinicians read common result patterns, when testing is appropriate, and how treatment decisions are made with your doctor.
What the C. diff toxin test is and why it matters
The C. diff toxin test looks for evidence of active Clostridioides difficile infection (often abbreviated CDI). The key idea is the difference between colonization and disease. Many healthy people, especially after a hospital stay, carry C. difficile in their intestines without any symptoms. According to the CDC, finding the germ is common even in homes where no one has been ill. Colonization alone is not an infection.
Disease happens when the bacteria multiply and release toxin A and toxin B, which damage the lining of the colon and cause watery diarrhea, cramping, and inflammation. So the practical goal of testing is to separate true, toxin-driven infection from harmless carriage. That distinction shapes whether treatment is needed and helps avoid treating people who are simply colonized.
Because diarrhea has many causes, your clinician interprets the test alongside your symptoms, recent antibiotic use, and medical history rather than relying on a single number.
The main C. diff testing methods
Laboratories use several tests, and each answers a slightly different question. No single test is perfect on its own, which is why modern laboratories usually combine them.
GDH antigen test
The glutamate dehydrogenase (GDH) test detects an enzyme produced by C. difficile. It is highly sensitive, meaning it rarely misses the organism, so a negative GDH result strongly argues against C. difficile. However, it cannot tell whether the strain is making toxins, so a positive GDH result by itself does not confirm disease. It works well as a first-step screen.
Toxin A/B EIA test
The toxin A/B enzyme immunoassay (EIA) looks directly for the toxins that cause illness. When it is positive, it points strongly toward active infection. Its limitation is lower sensitivity: toxins can break down quickly if the sample is not kept cool, as MedlinePlus notes, so a negative toxin result alone does not rule out infection.
NAAT or PCR test
A nucleic acid amplification test (NAAT), often a PCR test, detects the gene that codes for toxin production. It is very sensitive and fast. The trade-off is that it finds the toxin gene even when the bacteria are present but not actively producing enough toxin to cause disease, so a positive NAAT can reflect colonization rather than infection.
The recommended multistep testing algorithm
Because each method has a blind spot, many laboratories use a multistep, or two-step, algorithm that combines a sensitive screen with a specific confirmation. A common approach starts with a GDH antigen test paired with a toxin A/B EIA. When the two agree, the result is usually clear. When they disagree, a NAAT is often used to help adjudicate the discordant result.
This strategy plays to each test’s strength: the GDH screen rarely misses the germ, the toxin test confirms active disease, and the NAAT resolves uncertain cases by checking for the toxin gene. The aim is to confirm genuine infection while reducing the chance of treating simple carriage.
| Test type | O que ele detecta | Strengths and limitations |
|---|---|---|
| GDH antigen | An enzyme made by C. difficile bacteria | Very sensitive screen; rarely misses the germ, but does not show whether toxins are being made |
| Toxin A/B EIA | Toxins A and B themselves | Specific for active toxin and disease, but less sensitive; toxins can degrade if the sample is not kept cool |
| NAAT or PCR | The gene that codes for toxin production | Very sensitive and fast, but can be positive in colonization without active disease |
How to interpret common result patterns
Results are usually read as a combination rather than one isolated value. The grid below shows how clinicians often think about GDH and toxin pairings. These are general patterns, not a diagnosis, and your clinician always interprets them in the context of your symptoms.
| GDH result | Toxin result | Interpretação típica |
|---|---|---|
| Positivo | Positivo | Consistent with active C. difficile infection in someone who has symptoms |
| Negativo | Negativo | C. difficile infection is unlikely; symptoms probably have another cause |
| Positivo | Negativo | Discordant; the germ is present but toxin was not detected, so this needs clinical correlation and often a NAAT to clarify |
A positive GDH with a negative toxin is the pattern that most often causes confusion. It can mean early or low-level infection, simple carriage, or toxin that degraded in the sample. This is exactly where a NAAT and your clinical picture help decide whether treatment is warranted. To understand how stool form fits the picture, your clinician may also review a guide to normal and abnormal stool consistency.
When C. diff toxin testing is appropriate
Testing is meant for people who actually have diarrhea. Both the CDC and MedlinePlus describe the main trigger as new, unexplained diarrhea, often three or more unformed or watery stools within 24 hours, frequently after recent antibiotics or a stay in a hospital or nursing home.
Two practical rules follow from how the tests work:
- Only diarrheal or unformed stool should be tested. Testing formed stool is discouraged because a positive result is likely to reflect colonization rather than disease.
- A test of cure is not recommended. After successful treatment, the germ can linger in the gut, so repeat testing would only show that bacteria remain, not whether you are still sick.
If your symptoms began soon after a course of antibiotics, your clinician may also consider how those medicines affect the bowel, a topic explored in this overview of antibióticos e constipação.
Turnaround time and the testing process
Collecting the sample is simple and needs no special preparation. You provide a fresh sample of loose or liquid stool in a clean container, keep it from mixing with urine or toilet water, and return it promptly, refrigerating it if there is a delay. NAAT and EIA-based tests are often resulted within about a day, though exact turnaround varies by laboratory and whether more than one test is run.
Because diarrhea has many causes, a C. diff test is sometimes ordered alongside other stool studies. Your clinician may compare it with results such as an ova and parasites stool test when a parasitic cause is possible, or with a fecal calprotectin test when intestinal inflammation needs to be assessed.
A high-level look at treatment
Treatment decisions belong to a clinician, and the points below are general background, not medical advice or a promise of any outcome. According to the CDC and Mayo Clinic, common steps may include the following.
- Stopping the triggering antibiotic when a clinician judges it safe, since the original antibiotic often set the stage for infection.
- Using oral therapies directed against C. difficile, such as vancomycin or fidaxomicin, typically for a defined course.
- Supporting hydration, because diarrhea can cause significant fluid loss.
- Considering fecal microbiota-based options for people who have repeated recurrences, an approach discussed below.
Blood markers sometimes help a clinician judge how the body is responding to a significant infection. In selected cases that may include a C-reactive protein inflammation marker ou a procalcitonin infection marker, interpreted together with symptoms.
Quando consultar um médico
Contact a healthcare professional if you develop diarrhea, especially after recent antibiotics or time in a healthcare facility. Seek prompt care if you notice warning signs such as severe or watery diarrhea many times a day, fever, marked abdominal pain or cramping, blood or pus in the stool, or signs of dehydration like dizziness, very dark urine, dry mouth, or reduced urination.
People aged 65 and older, those with a weakened immune system, and anyone with a previous C. difficile infection face higher risk and should not delay seeking care. Severe abdominal swelling, persistent vomiting, fainting, or confusion warrant urgent evaluation. Persistent diarrhea also overlaps with conditions such as doença de Crohn e síndrome do intestino irritável, which a clinician can help distinguish.
Glossário de termos-chave
| Prazo | Definição |
|---|---|
| Clostridioides difficile | A bacterium that can cause diarrhea and colitis when it produces toxins; formerly named Clostridium difficile |
| Toxin A and toxin B | The two toxins released by C. difficile that damage the colon lining and cause symptoms |
| Colonization | Carrying the bacteria in the gut without active disease or symptoms |
| GDH antigen | An enzyme made by C. difficile used as a sensitive screening marker |
| EIA | Enzyme immunoassay, a laboratory method used here to detect toxins A and B |
| NAAT | Nucleic acid amplification test, often a PCR test, that detects the toxin gene |
| Colitis | Inflammation of the colon, which can cause pain and diarrhea |
| Discordant result | When two tests disagree, such as a positive GDH with a negative toxin, prompting further testing |
Perguntas frequentes
How do you get C. diff?
C. difficile spreads through tiny amounts of stool, often by touching a contaminated surface and then the mouth. The germ forms hardy spores that survive on surfaces. Most infections occur during or shortly after antibiotics, which disrupt the protective gut bacteria and let C. difficile grow.
Is C. diff contagious?
Yes. C. difficile can spread from person to person, particularly in hospitals and nursing homes. Washing hands with soap and water after using the bathroom and before eating helps reduce spread, since alcohol-based sanitizers do not reliably destroy the spores.
What are common symptoms of a C. diff infection?
Typical symptoms include watery diarrhea three or more times a day, abdominal pain or cramping, fever, nausea, and loss of appetite. Severe infection can cause more frequent diarrhea, dehydration, and, rarely, serious complications of the colon.
Does a stool culture test for C. diff?
A general stool culture is not the usual way to confirm C. difficile infection. Instead, clinicians order dedicated tests, such as a GDH antigen test, a toxin A/B EIA, and a NAAT or PCR test, often in a multistep algorithm, because these distinguish toxin-producing infection from simple carriage.
What does a positive GDH but negative toxin result mean?
This discordant pattern means C. difficile is present but no toxin was detected. It can reflect early infection, colonization, or toxin that degraded in the sample. A NAAT and your symptoms help your clinician decide whether the result represents true infection.
Why did the name change from Clostridium to Clostridioides difficile?
Scientists reclassified the bacterium based on genetic analysis, which placed it in a different group than other Clostridium species. The organism is now called Clostridioides difficile, although you may still see the older name Clostridium difficile in some references.
Últimos avanços científicos
Research from 2023 to 2026 reinforces both why the toxin distinction matters and how recurrent infection can be managed. The findings below are summarized at a high level and do not replace personalized medical advice.
A 2025 matched case-control study from Duke University Health System, published in Infection Control and Hospital Epidemiology, followed colonized patients identified by two-step testing. It distinguished colonization (NAAT positive, toxin negative) from infection (NAAT positive, toxin positive) and found that sustained exposure to high-risk antibiotics was a strong predictor of progressing from carriage to true infection. This single-center observational study supports the clinical logic behind toxin-based, multistep testing and careful antibiotic use.
For recurrent infection, a 2023 Cochrane systematic review of six randomized trials in 320 immunocompetent adults concluded that fecal microbiota transplantation likely produces a large increase in resolution of recurrent C. difficile infection compared with alternatives such as antibiotics, rated as moderate-certainty evidence. As a pooled review of controlled trials, it represents a relatively high level of evidence, though the authors noted that safety data were limited by small event numbers.
Newer microbiota-based products have since reached approval. A 2025 Phase III analysis in Inflammatory Bowel Diseases reported that fecal microbiota, live-jslm, the first single-dose live biotherapeutic approved by the US Food and Drug Administration to prevent recurrent C. difficile infection, achieved high sustained response rates even in participants with inflammatory bowel disease. These results are encouraging, and decisions about such therapies remain individualized and made with a specialist.
Fontes
- About C. diff (Centers for Disease Control and Prevention)
- C. diff Testing (MedlinePlus, U.S. National Library of Medicine)
- C. difficile infection: Symptoms and causes (Mayo Clinic)
- Chang S, et al. Risk factors for progression from colonization (NAAT+/toxin-) to infection (toxin+) following symptomatic retesting. Infection Control and Hospital Epidemiology. 2025. https://doi.org/10.1017/ice.2025.10377
- Minkoff NZ, et al. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile. Cochrane Database of Systematic Reviews. 2023. https://doi.org/10.1002/14651858.CD013871.pub2
- Allegretti JR, et al. Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Participants With Inflammatory Bowel Disease (PUNCH CD3-OLS). Inflammatory Bowel Diseases. 2025. https://doi.org/10.1093/ibd/izae291
Leitura complementar
- Calprotectina fecal: interpretando os resultados dos testes
- Exame de fezes para ovos e parasitas: como entender os resultados
- Consistência das fezes: entendendo as alterações normais e anormais.
- Síndrome do intestino irritável: como controlar
- Crohn’s disease: causes, symptoms, and treatments
Making sense of a C. diff toxin test is easier when you connect it to your other results, such as a toxin A/B test, a GDH antigen screen, a stool calprotectin level, or an inflammation marker like C-reactive protein. AI DiagMe helps you understand what these results may mean and what to ask your clinician next. It does not diagnose conditions and does not replace your doctor.
Entenda os resultados dos seus exames com o AI DiagMe.
Obtenha a interpretação dos seus resultados em minutos.
